Alliance Pharma Future Growth
Future criteria checks 4/6
Alliance Pharma is forecast to grow earnings and revenue by 72.6% and 5.4% per annum respectively. EPS is expected to grow by 87.7% per annum. Return on equity is forecast to be 11.4% in 3 years.
Key information
72.6%
Earnings growth rate
87.7%
EPS growth rate
| Pharmaceuticals earnings growth | 14.9% |
| Revenue growth rate | 5.4% |
| Future return on equity | 11.4% |
| Analyst coverage | Good |
| Last updated | 27 Jun 2024 |
Recent future growth updates
Recent updates
Is Alliance Pharma (LON:APH) A Risky Investment?
Jun 21
Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet
Feb 23Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)
Nov 21We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt
May 26Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models
Mar 24We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt
Sep 30An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued
May 28Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet
Mar 30Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?
Dec 24Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?
Nov 19
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 213 | 23 | 34 | 44 | 5 |
| 12/31/2025 | 205 | 20 | 31 | 42 | 6 |
| 12/31/2024 | 191 | 16 | 29 | 38 | 5 |
| 12/31/2023 | 181 | -33 | 31 | 31 | N/A |
| 9/30/2023 | 175 | -31 | 30 | 30 | N/A |
| 6/30/2023 | 170 | -7 | 29 | 29 | N/A |
| 3/31/2023 | 169 | -3 | 25 | 25 | N/A |
| 12/31/2022 | 167 | -21 | 20 | 21 | N/A |
| 9/30/2022 | 165 | -5 | 26 | 27 | N/A |
| 6/30/2022 | 163 | 12 | 32 | 34 | N/A |
| 3/31/2022 | 163 | 10 | 33 | 36 | N/A |
| 12/31/2021 | 163 | 7 | 34 | 39 | N/A |
| 9/30/2021 | 155 | 13 | 34 | 39 | N/A |
| 6/30/2021 | 147 | 18 | 34 | 39 | N/A |
| 3/31/2021 | 138 | 13 | 36 | 40 | N/A |
| 12/31/2020 | 130 | 8 | 38 | 42 | N/A |
| 9/30/2020 | 131 | 10 | 33 | 37 | N/A |
| 6/30/2020 | 131 | 11 | 29 | 32 | N/A |
| 3/31/2020 | 133 | 18 | 30 | 34 | N/A |
| 12/31/2019 | 136 | 25 | 32 | 36 | N/A |
| 9/30/2019 | 133 | 23 | 28 | 32 | N/A |
| 6/30/2019 | 130 | 21 | 24 | 27 | N/A |
| 3/31/2019 | 124 | 20 | 21 | 25 | N/A |
| 12/31/2018 | 118 | 18 | 19 | 22 | N/A |
| 9/30/2018 | 112 | 21 | 22 | 24 | N/A |
| 6/30/2018 | 107 | 24 | 24 | 26 | N/A |
| 3/31/2018 | 104 | 27 | 24 | 27 | N/A |
| 12/31/2017 | 102 | 29 | 24 | 27 | N/A |
| 9/30/2017 | 101 | 25 | N/A | 27 | N/A |
| 6/30/2017 | 100 | 22 | N/A | 26 | N/A |
| 3/31/2017 | 99 | 20 | N/A | 22 | N/A |
| 12/31/2016 | 97 | 18 | N/A | 17 | N/A |
| 9/30/2016 | 85 | 18 | N/A | 13 | N/A |
| 6/30/2016 | 72 | 18 | N/A | 9 | N/A |
| 3/31/2016 | 60 | 15 | N/A | 9 | N/A |
| 12/31/2015 | 48 | 13 | N/A | 8 | N/A |
| 9/30/2015 | 47 | 11 | N/A | 9 | N/A |
| 6/30/2015 | 45 | 8 | N/A | 9 | N/A |
| 3/31/2015 | 44 | 8 | N/A | 10 | N/A |
| 12/31/2014 | 44 | 8 | N/A | 11 | N/A |
| 9/30/2014 | 44 | 8 | N/A | 11 | N/A |
| 6/30/2014 | 44 | 9 | N/A | 10 | N/A |
| 3/31/2014 | 45 | 9 | N/A | 10 | N/A |
| 12/31/2013 | 45 | 10 | N/A | 9 | N/A |
| 9/30/2013 | 45 | 10 | N/A | 10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: APH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).
Earnings vs Market: APH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: APH is expected to become profitable in the next 3 years.
Revenue vs Market: APH's revenue (5.4% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: APH's revenue (5.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: APH's Return on Equity is forecast to be low in 3 years time (11.4%).